ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John R. Doty
Donald B. Doty
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doty, J. R.
Right arrow Articles by Doty, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doty, J. R.
Right arrow Articles by Doty, D. B.

Ann Thorac Surg 1999;67:1111-1116
© 1999 The Society of Thoracic Surgeons


Original Articles

Superior vena cava obstruction: bypass using spiral vein graft

John R. Doty, MDa, Jean H. Flores, RNa, Donald B. Doty, MDa

a Department of Surgery, LDS Hospital, Salt Lake City, Utah, USA

Accepted for publication December 17, 1998.

Address reprint requests to Dr Donald Doty, 324 Tenth Ave, Salt Lake City, UT 84103
e-mail: ldddoty{at}ihc.com

Background. Previous midterm experience with the composite spiral saphenous vein graft to bypass the obstructed superior vena cava (SVC) has been favorable. This study looks at the long-term results in patients followed for up to 23 years.

Methods. Sixteen patients aged 17 to 68 years had operation for obstruction of the SVC with SVC syndrome caused by benign disease. Eleven patients had fibrosing mediastinitis with or without caseous necrosis, 4 had thrombosis caused by a catheter or a pacemaker electrode, and 1 had spontaneous thrombosis. All operations were performed using a composite spiral vein graft constructed from the patient’s own saphenous vein. Graft diameter ranged from 9.5 to 15.0 mm. Ten grafts were from the left innominate vein, and six grafts were from the right or left internal jugular vein. The grafts were placed to the right atrial appendage in all patients except 1. Follow-up extends from 1 month to 23 years 8 months (mean follow-up, 10.9 years).

Results. Fourteen of 16 grafts remain patent for up to 23 years, and all patients but 1 are free from SVC syndrome. One patient required revision of the graft for thrombosis 4 days after operation. Two grafts closed during the first year after operation: one because of recurrence of spontaneous venous thrombosis and the other because of aggressive fibrosing mediastinitis requiring operation for graft revision three times over a 12-year period prior to death.

Conclusions. These data demonstrate that a spiral vein bypass graft for treatment of the obstructed SVC relieves SVC syndrome and has excellent long-term patency.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Pompeo, F. Stella, A. Ippoliti, and T. C. Mineo
Extra-anatomic bypass of the superior vena cava after successful stenting for fibrosing mediastinitis
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 220 - 221.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W. D. Lu, F. L. Yu, and Z. S. Wu
Superior vena cava reconstruction using bovine jugular vein conduit
Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 816 - 817.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Xu, C. Alexiou, M. Tofeig, and T. J. Spyt
Management of superior vena cava obstruction syndrome due to thrombosis of a Contegra conduit used to re-establish the innominate vein-to-right atrium continuity
Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 517 - 518.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Ruge, S. M. Wildhirt, M. Poerner, N. Mayr, R. Bauernschmitt, S. Martinoff, and R. Lange
Severe Superior Vena Cava Syndrome after Transvenous Pacemaker Implantation
Ann. Thorac. Surg., December 1, 2006; 82(6): e41 - e42.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Bays, C. Rajakaruna, E. Sheffield, and A. Morgan
Fibrosing mediastinitis as a cause of superior vena cava syndrome
Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 453 - 455.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Kostopoulou, E. Sbarouni, E. G. Livanis, G. N. Theodorakis, and D. Kremastinos
Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient
Europace, January 1, 2004; 6(3): 205 - 208.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Caples and J. Utz
Successful Surgical Treatment of Recurrent Pleural Effusions From SVC Syndrome Related to Mediastinal Fibrosis Diagnosed 24 Years Earlier
Chest Meeting Abstracts, October 1, 2003; 124(4): 273S - 274.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. E. Rossi, H. P. McAdams, M. L. Rosado-de-Christenson, T. J. Franks, and J. R. Galvin
Fibrosing Mediastinitis
RadioGraphics, May 1, 2001; 21(3): 737 - 757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.